Ainos, Inc. (NASDAQ:AIMD) Sees Large Drop in Short Interest

Ainos, Inc. (NASDAQ:AIMD) saw a large decline in short interest during the month of March. As of March 31st, there was short interest totalling 78,900 shares, a decline of 13.4% from the March 15th total of 91,100 shares. Approximately 4.8% of the shares of the stock are sold short. Based on an average trading volume of 1,840,000 shares, the short-interest ratio is presently 0.0 days.

Ainos Price Performance

NASDAQ AIMD traded down $0.01 on Tuesday, reaching $1.01. The company had a trading volume of 23,423 shares, compared to its average volume of 1,640,986. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.72 and a current ratio of 1.85. The firm’s 50 day moving average price is $1.12 and its 200 day moving average price is $2.04. Ainos has a 12 month low of $0.79 and a 12 month high of $6.10.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.